The candidate SNP sites identified by our prediction model can be applied as biomarkers for the pathologic evaluation of CRC, given that the state of MACROD2 has been confirmed to be a significant signal in intestinal cancers. The gene discussed is MACROD2; the disease is intestinal cancer.